Effects of Intestinal Flora and Local Renin-angiotensin System on Diabetic Nephropathy and Traditional Chinese Medicine Intervention： A Review

YANG Chaomao; LI Yuanyuan; ZHANG Shunxiao; GAO Jiandong

doi:10.13422/j.cnki.syfjx.202202124

您当前的位置：

首页 >

文章列表页 >

Effects of Intestinal Flora and Local Renin-angiotensin System on Diabetic Nephropathy and Traditional Chinese Medicine Intervention： A Review

更新时间：2023-06-30

- Effects of Intestinal Flora and Local Renin-angiotensin System on Diabetic Nephropathy and Traditional Chinese Medicine Intervention： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 15, Pages: 242-248(2023)
- 作者机构：
  
  1.上海中医药大学附属曙光医院宝山分院，上海 201999
  2.上海中医药大学附属曙光医院，上海 201203
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.202202124
  CLC： R22;R242;R2-031;R285.5
- Published：05 August 2023，
  
  Published Online：02 September 2022，
  
  Received：11 May 2022，
- 稿件说明：
扫描看全文
杨超茅,李园园,张顺宵等.肠道菌群与局部肾素-血管紧张素系统对糖尿病肾病的影响及中医药研究进展[J].中国实验方剂学杂志,2023,29(15):242-248.

YANG Chaomao,LI Yuanyuan,ZHANG Shunxiao,et al.Effects of Intestinal Flora and Local Renin-angiotensin System on Diabetic Nephropathy and Traditional Chinese Medicine Intervention： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(15):242-248.
杨超茅,李园园,张顺宵等.肠道菌群与局部肾素-血管紧张素系统对糖尿病肾病的影响及中医药研究进展[J].中国实验方剂学杂志,2023,29(15):242-248. DOI： 10.13422/j.cnki.syfjx.202202124.

YANG Chaomao,LI Yuanyuan,ZHANG Shunxiao,et al.Effects of Intestinal Flora and Local Renin-angiotensin System on Diabetic Nephropathy and Traditional Chinese Medicine Intervention： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(15):242-248. DOI： 10.13422/j.cnki.syfjx.202202124.

摘要

糖尿病肾病（DN）是临床常见的糖尿病并发症，是导致终末期肾脏病（ESRD）的主要原因，同时也是糖尿病患者生存的关键决定因素。糖尿病肾病发病机制复杂，目前认为与血流动力学异常、肠道菌群紊乱、糖脂代谢紊乱、氧化应激、遗传易感性及蛋白非酶糖基化等有关。局部肾素-血管紧张素系统（RAS）一直都是糖尿病肾病致病性和进行性变化的核心，其一旦被激活，会进而诱发血管内产生大量氧自由基，破坏内皮功能，影响机体微循环。随着最近的研究发现，肠道菌群及其代谢产物可能通过激活或者拮抗局部RAS从而影响DN的发生发展。中药治疗糖尿病肾病相比单纯西药治疗具有多靶点、不良反应小等优势。近年来不少中医学者发现单味药及其有效成分提取物、中药复方可以通过调节局部RAS或者调节肠道菌群的方式改善肾脏功能，如补脾的党参、山药、白术、茯苓，也有补肾的熟地黄、山茱萸、太子参；以及具有活血化瘀通络功效的水蛭、丹参、当归。该文整理并归纳了肠道菌群与局部RAS在DN的发生发展过程中起到的作用，并且参考近几年中药干预DN的动物实验或临床试验，进行分析、归纳，总结，以期为DN的中西医结合治疗提供更多的治疗策略和理论依据。

Abstract

Diabetic nephropathy （DN） is a common clinical complication of diabetes， the main cause of end-stage renal disease （ESRD）， and a key determinant of survival in diabetic patients. The pathogenesis of DN is complex， and it is currently believed to be associated with hemodynamic abnormalities， intestinal flora disturbances， glucose and lipid metabolism disorders， oxidative stress， genetic susceptibility， and protein non-enzymatic glycosylation. The local renin-angiotensin system （RAS） has always been the core of the pathogenic and progressive changes of DN. Once activated， it will induce the massive release of oxygen free radicals in the blood vessels， damage the endothelial function， and affect the microcirculation of the body. The recent studies demonstrate that intestinal flora and its metabolites may affect the occurrence and development of DN by activating or antagonizing the local RAS. Compared with western medicine treatment， traditional Chinese medicine （TCM） has the advantages of multiple targets and little toxic and side effects. Many TCM scholars have found that single herbs， their active ingredient extracts， and TCM compound prescriptions can improve kidney function by regulating the local RAS or intestinal flora. Specifically， the Chinese medicinal materials tonifying spleen （Codonopsis Radix， Dioscoreae Rhizoma， Atractylodis Macrocephalae Rhizoma， and Poria）， replenishing kidney （Rehmanniae Radix Praeparata， Corni Fructus， and Pseudostellariae Radix）， and activating blood， resolving stasis， and dredging collaterals （Hirudo， Salviae Miltiorrhizae Radix et Rhizoma， and Angelicae Sinensis Radix） have the regulatory effect. This article summarizes the roles of intestinal flora and local RAS in the occurrence and development of DN， and analyzes the animal experiments or clinical trials of TCM intervention in DN in recent years， aiming to provide more therapies and a theoretical basis for the treatment of DN with integrated TCM and Western medicine.

关键词

糖尿病肾病（DN）肠道菌群肾素-血管紧张素系统（RAS）中医中药

Keywords

diabetic nephropathy（DN）intestinal florarenin-angiotensin system （RAS）traditional Chinse medicineChinese medicinal materials

references

中华医学会糖尿病学分会.中国2型糖尿病防治指南（2020年版）（上）［J］.中国实用内科杂志，2021，41（8）：668-695.

蔡新杰，邢光辉.胰岛自身抗体和生化指标在糖尿病分型诊断中的应用价值［J］.临床研究，2019，27（1）：133-134.

UMANATH K，LEWIS J B.Update on diabetic nephropathy： Core curriculum 2018［J］.Am J Kidney Dis，2018，71（6）：884-895.

张晶露，邱琳，雒晓春.糖尿病肾病发病机制研究进展［J］.医学综述，2017，23（8）：1623-1627.

李嘉欣，马婷婷，南一，等.糖尿病肾病发病机制研究进展［J］.临床肾脏病杂志，2019，19（11）：860-864.

WYSOCKI J，YE M，KHATTAB A M， et al. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy［J］.Kidney Int，2017，91（6）：1336-1346.

黄雅兰，黄国东，蔡林坤，等.壮药复方仙草颗粒治疗早期糖尿病肾病的临床疗效及对患者内皮功能、血液流变学、免疫功能的影响［J］.中国全科医学，2020，23（24）：3086-3093.

朱文婧，卓宇苗，梁钊雄.阿魏酸哌嗪辅助治疗糖尿病肾病的效果及对患者肾功能、血液流变学指标的影响［J］.海南医学，2020，31（7）：835-837.

ZHANG L，LONG J，JIANG W，et al.Trends in chronic kidney disease in China［J］.N Engl J Med，2016，375（9）：905-906.

STOCKLER-PINTO M B，SALDANHA J F，YI D，et al.The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells［J］.Free Radic Res，2016，50（3）：337-344．

FORSLUND K，SUNAGAWA S，KULTIMA J R，et al.Country-specific antibiotic use practices impact the human gut resistome［J］.Genome Res，2013，23（7）：1163-1169.

KANBAY M，ONAL E M，AFSAR B，et al. The crosstalk of gut microbiota and chronic kidney disease： Role of inflammation，proteinuria， hypertension， and diabetes mellitus［J］.Int Urol Nephrol，2018，50（8）：1453-1466.

CROXEN M A，LAW R J，SCHOLZ R，et al.Recent advances in understanding enteric pathogenic escherichia coli［J］.Clin Microbiol Rev，2013，26（4）：822-880.

DE KORT S，KESZTHELYI D，MASCLEE A A. Leaky gut and diabetes mellitus： What is the link？［J］.Obes Rev，2011，12（6）：449-458.

DU X，LIU J，XUE Y，et al.Alteration of gut microbial profile in patients with diabetic nephropathy［J］.Endocrine，2021，73（1）：71-84.

CASÉN C，VEBØ H C，SEKELJA M，et al.Deviations in human gut microbiota： A novel diagnostic test for determining dysbiosis in patients with IBS or IBD［J］.Aliment Pharmacol Ther， 2015，42（1）：71-83．

BARRIOS C，BEAUMONT M，PALLISTER T，et al.Gut-microbiota-metabolite axis in early renal function decline［J］.Plos One，2015，10（8）： e0134311.

TAO S，LI L Z， LI L，et al.Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy，type 2 diabetes mellitus and healthy controls： An analysis of the gut microbiota composition［J］.Acta Diabetol，2019，56（5）：581-592.

SALGUERO M V，AL-OBAIDE M，SINGH R，et al.Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease［J］.Exp Ther Med，2019，18（5）：3461-3469.

RAHIMI Z.The role of renin angiotensin aldosterone system genes in diabeteic nephropathy［J］.Can J Diabetes， 2016， 40（2）：178-183.

KIMBERLY C，GILBERT A.Aldosterone and inflammation［J］.Curr Opin Endocrinol Diabetes Obes，2010， 17（3）： 199-204.

杨超茅，杨志新，马晓玲.AGEs-RAGE信号通路在糖尿病肾病中的作用机制及中医药研究进展［J］.中医学报，2019，34（9）：1864-1868.

PETI-PETERDI J.High glucose and renin release： the role of succinate and GPR91［J］.Kidney Int， 2010，78（12）： 1214-1217.

MATAVELLI L C， ZATZ R，SIRAGY H M.A nonpeptide angiotensinⅡ type 2 receptor agonist prevents renal inflammation in early diabetes［J］.J Cardiovasc Pharmacol，2015，65（4）：371-376.

PALM F，NANGAKU M，FASCHING A，et al.Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress［J］.Am J Physiol Renal Physiol，2010，299（2）：F380-386.

NIEWCZAS M A，SIRICH T L，MATHEW A V，et al.Uremic solutes and risk of end-stage renal disease in type 2 diabetes： Metabolomic study［J］.Kidney Int，2014，85（5）：1214-1224.

SUN C Y，CHANG S C，WU M S.Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition［J］.PLoS One，2012，7（3）：e34026.

BADER M. ACE2，angiotensin-（1-7），and Mas：The other side of the coin［J］.Pflugers Arch，2013，465（1）：79-85.

PLUZNICK J L，PROTZKO R J，GEVORGYAN H，et al.Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation［J］.Proc Natl Acad Sci USA，2013，110（11）：4410-4415.

KONING A M，FRENAY A R，LEUVENINK H G，et al.Hydrogen sulfide in renal physiology， disease and transplantation-the smell of renal protection［J］.Nitric Oxide，2015，46（4）： 37-49.

XUE H，YUAN P，NI J，et al.H2S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation［J］. PLoS One，2013，8（9）：e74366.

WANG L，ZHU Q，LU A，et al.Sodium butyrate suppresses angiotensin Ⅱ-induced hypertension by inhibition of renal （pro）renin receptor and intrarenal renin-angiotensin system［J］J Hypertens，2017，35（9）：1899-1908.

GONZALEZ-GONZALEZ C，GIBSON T，JAUREGI P.Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by bifidobacterium bifidum MF20/5［J］. Int J Food Microbiol，2013，167（2）：131-137.

张文杰，赖星海，陈佳薇.山药多糖治疗肥胖糖尿病肾病大鼠的效果观察及对其肾功能和肠道微生态的影响［J］.中国微生态学杂志，2021，33（1）：37-42.

戴新新，蔡红蝶，宿树兰，等.地黄叶对糖尿病肾病大鼠肠道菌群的调节作用［J］.药学学报，2017，52（11）：1683-1691.

LI X W，CHEN H P，HE Y Y，et al.Effects of rich-polyphenols extract of dendrobium loddigesii on anti-diabetic， anti-inflammatory， anti-oxidant， and gut microbiota modulation in db/db mice［J］.Molecules， 2018，23（12）：1-20.

徐卓，项想，尚尔鑫，等.丹参茎叶总酚酸对2型糖尿病肾病小鼠肠道菌群和短链脂肪酸的调节作用［J］.药学学报，2021，56（4）：1035-1048.

ZHAO J，ZHANG Q L，SHEN J H，et al.Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy［J］.Acta Pharmacol Sin，2019，40（4）：507-513.

蔡红蝶，宿树兰，郭建明，等.丹参对糖尿病肾损伤大鼠肠道菌群多样性的影响［J］.中国中药杂志，2021，46（2）：426-435.

王利民，池文婕，王玮，等.阿魏酸钠对糖尿病肾病患者肠道菌群的影响［J］.新疆医科大学学报，2018，41（1）：21-24.

ZHAO T，ZHANG H，YIN X，et al.Tangshen formula modulates gut microbiota and reduces gut-derived toxins in diabetic nephropathy rats［J］.Biomed Pharmacother，2020，129：110325.

WEI H L，WANG L，AN Z C.QiDiTangShen granules modulated the gut microbiome composition and improved bile acid prfiles in a mouse model of diabetic nephropathy［J］.Biomed Pharmacother，2021， doi：10.1016/j.biopha.2020.111061http://dx.doi.org/10.1016/j.biopha.2020.111061.

杜小梅，潘薇，梁颖兰，等.参芪地黄汤加减治疗气阴两虚型糖尿病肾病疗效观察及对肠道菌群和炎症因子的影响［J］.中药新药与临床药理，2021，32（4）：566-572.

DONG Z，CHEN C X.Effect of catalpol on diabetic nephropathy in rats［J］.Phytomedicine， 2013，20（11）：1023-1029.

YUAN J，WANG X，CHEN T，et al.Salvia miltorrhiza depresses plasminogen activator inhibitor-1 production through inhibition of angiotensin Ⅱ［J］.Am J Chin Med，2008，36 （5）：1005-1015．

阮旭，杨晔，徐仲儒，等.丹参注射液对AngⅡ诱导NRK-52E细胞损伤的保护作用［J］.中成药，2018，40（5）：1170-1173．

邵福平，阮旭，李梦颖，等.丹参注射剂体内外对糖尿病状态下肾小管AT1表达的影响［J］.中成药，2020，42（5）：1169-1173.

刘银，苏笮斌，胡力文，等.某中药复方对早期糖尿病肾病大鼠肾组织肾素-血管紧张素系统的影响因素初探［J］.现代预防医学，2018，45（11）：2034-2038.

张新志，曹和欣，吴锋，等.糖肾宁保护糖尿病肾病大鼠肾小管功能的研究［J］.上海中医药杂志，2014，48（9）：80-83.

贾丽荣，赵印涛，王烨，等.益气养阴、祛瘀化浊中药复方对糖尿病肾病大鼠β2-MG、ET、AngⅡ的影响［J］.辽宁中医杂志，2018，45（7）：1494-1496.

吴开明，常健菲，李姝花，等.肾白宁对糖尿病肾病大鼠ACE2蛋白及基因表达的影响［J］.中医学报，2017，32（5）：747-749.

徐晶，马二卫，白璐，等.化瘀通络中药对糖尿病肾病大鼠肾皮质血管紧张素转化酶2-血管紧张素（1-7）-Mas轴的影响［J］.中国中西医结合杂志，2014，34（6）：714-721.

MARKKU L，PER-HENRIK G.The gut-kidney axis： Putative interconnections between gastrointestinal and renal disorders［J］.Front Endocrinol （Lausanne），2018，9：553.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Chaihu Shugansan and Its Modified Formulas in Treatment of Functional Dyspepsia： A Review

Top 10 Academic Progress of Traditional Chinese Medicine in 2023

Relationship between "Nutrients-intestinal Flora" and Type 2 Diabetes Mellitus Based on Theory of "Linkage between Spleen and Small Intestine"

Exploring Synergistic Mechanism of Processing with Vinegar on Olibanum in Treatment of Ulcerative Colitis Based on Intestinal Flora

Interaction Between Bruceoside B and Intestinal Flora and Its Inhibitory Effect on Human Lung Cancer A549 Cells

Related Author

ZHAO Wei

ZHANG Yaxi

JIANG Yuxuan

DAI Jiaqing

GUO Lifang

China Association of Chinese Medicine

CHEN Zhichao

LIN Qiaoni

Related Institution

Graduate School of Hebei University of Chinese Medicine

Hebei Provincial Hospital of Traditional Chinese Medicine

Liaoning University of Traditional Chinese Medicine

Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences

Jiangxi University of Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰